Adipo-R1 and Adipo-R2 expression in colorectal adenomas and carcinomas

Asian Pacific Journal of Cancer Prevention

Volumn 16, Issue 1, 2015, Pages 367-372

  Ayyildiz, Talat ^a   Dolar, Enver ^b   Ugras, Nesrin ^b   Eminler, Ahmet Tarik ^c   Erturk, Banu ^d   Adim, Saduman Balaban ^b   Yerci, Omer ^b  

^a ONDOKUZ MAYIS UNIVERSITY   (Turkey)

^b ULUDAG UNIVERSITY   (Turkey)

^c SAKARYA UNIVERSITY   (Turkey)

^d ERCIYES UNIVERSITY   (Turkey)

Author keywords

Adiponectin; AdipoR1; AdipoR2; Colorectal carcinoma; Polyps progression

Indexed keywords

ADIPONECTIN; ADIPONECTIN RECEPTOR; ADIPOR1 PROTEIN, HUMAN; ADIPOR2 PROTEIN, HUMAN;

ADENOMA; ADENOMATOUS POLYP; ADIPOCYTE; BIOSYNTHESIS; CARCINOMA; COLORECTAL TUMOR; FEMALE; GENE EXPRESSION; HUMAN; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; RETROSPECTIVE STUDY;

ADENOMA; ADENOMATOUS POLYPS; ADIPOCYTES; ADIPONECTIN; CARCINOMA; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION; HUMANS; MALE; MIDDLE AGED; RECEPTORS, ADIPONECTIN; RETROSPECTIVE STUDIES;

EID: 84924270405     PISSN: 15137368     EISSN: None     Source Type: Journal    
DOI: 10.7314/APJCP.2015.16.1.367     Document Type: Article

References (32)

1. Ayyildiz T, Dolar E, Ugras N, Adim SB, Yerci O (2014a). Association of adiponectin receptor (adipo-r1/-r2) expression and colorectal cancer. Asian Pac J Cancer Prev, 15, 9385-90.
2. Ayyildiz T, Dolar E, Ugras N, et al (2014b). Lack of any prognostic relationship between adiponectin receptor (Adipo R1/R2) expression for early/advanced stage gastric cancer. Asian Pac J Cancer Prev, 15, 4711-16.
3. Barresi V, Grosso M, Giuffre G, Tuccari G, Barresi G (2009a). The expression of adiponectin receptors Adipo-R1 and Adipo-R2 is associated with an intestinal histotype and longer survival in gastric carcinoma. J Clin Pathol, 62, 705-9.
4. Barresi V, Tuccari G, Barresi G (2009b). Adiponectin immunohistochemical expression in colorectal cancer and its correlation with histological grade and tumour microvessel density. Pathology, 41, 533-8.
5. Bobe G, Murphy G, Rogers CJ, et al (2010). Serum adiponectin, leptin,C-peptide, homocysteine, and colorectal adenoma recurrence in the Polyp Prevention Trial. Cancer Epidemiol Biomarkers Prev, 19, 1441-52.
6. Brakenhielm E, Veitonmaki N, Cao R, et al (2004). Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis. Proc Natl Acad Sci USA, 101, 2476-81.
7. Bresalier RS (2010). Colorectal cancer. In'Sleisenger and Fordtran's Gastrointestinal and Liver Disease' Eds Feldman M, Friedman LS and Brandt LJ. Saunders, an imprint of Elsevier Inc. Philadelphia, pp 2191-239.
8. Canhoroz M, Kanat O, Saraydaroglu O, et al (2014). Clinical significance of adiponectin expression in colon cancer patients. J Cancer Res Ther, 10, 347-53
9. Chronis A, Thomopoulos K, Sapountzis A, et al (2011). Adiposity factors are not related to the presence of colorectal adenomas. Clin Exp Gastroenterol, 4, 257-61.
10. Dalamaga M, Diakopoulos KN, Mantzoros CS (2012). The role of adiponectin in cancer: a review of current evidence. Endocr Rev, 33, 547-94.
11. Danese E, Minicozzi AM, Montagnana M, et al (2013). Lack of an association between circulating adiponectin levels and risk of colorectal adenoma. Clin Lab, 59, 211-4.
12. Goldfine AB, Kahn CR (2003). Adiponectin: linking the fat cell to insulin sensitivity. Lancet, 362, 1431-2.
13. Gulcelik MA, Colakoglu K, Dincer H, et al (2012). Associations between adiponectin and two different cancers: breast and colon. Asian Pac J Cancer Prev, 13, 395-8.
14. Hebbard L, Ranscht B (2014). Multifaceted roles of adiponectin in cancer. Best Pract Res Clin Endocrinol Metab, 28, 59-69.
15. Joshi RK, Lee SA (2014). Obesity related adipokines and colorectal cancer: a review and meta-analysis. Asian Pac J Cancer Prev, 15, 397-405.
16. Kim AY, Lee YS, Kim KH, et al (2010). Adiponectin represses colon cancer cell proliferation via AdipoR1-and-R2- mediated AMPK activation. Mol Endocrinol, 24, 1441-52.
17. Lukanova A, Soderberg S, Kaaks R, Jellum E, Stattin P (2006). Serum adiponectin is not associated with risk of CRC. Cancer Epidemiol Biomarkers Prev, 15, 401-2.
18. Lysaght J, van der Stok EP, Allott EH, et al (2011). Pro-inflammatory and tumour proliferative properties of excess visceral adipose tissue. Cancer Lett, 312, 62-72.
19. Matsuzawa Y, Shimomura I, Kihara S, et al (2003). Importance of adipocytokines in obesityrelated diseases. Horm Res, 3, 56-9.
20. Ouchi N, Kihara S, Arita Y, et al (1999). Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation, 100, 2473-6.
21. Ouchi N, Kihara S, Arita Y, et al (2000). Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation, 102, 1296-301.
22. Ouchi N, Kihara S, Arita Y, et al (2001). Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocytederived macrophages. Circulation, 103, 1057-63.
23. Otake S, Takeda H, Suzuki Y, et al (2005). Association of visceral fat accumulation and plasma adiponectin with colorectal adenoma: evidence for participation of insulin resistance. Clin Cancer Res, 11, 3642-6.
24. Saxena A, Baliga MS, Ponemone V, et al (2013). Mucus and adiponectin deficiency: role inchronic inflammation-induced colon cancer. Int J Colorectal Dis, 28, 1267-79.
25. Siegel R, Desantis C, Jemal A (2014). Colorectal cancer statistics, 2014. CA Cancer J Clin, 64, 104-17
26. Sugiyama M, Takahashi H, Hosono K, et al (2009). Adiponectin inhibits colorectal cancer cell growth through the AMPK/ mTOR pathway. Int J Oncol, 34, 339-44.
27. Tilg H, Moschen AR (2014). Mechanisms behind the link between obesity and gastrointestinal cancers. Best Pract Res Clin Gastroenterol, 28, 599-610.
28. Wei EK, Giovannucci E, Fuchs CS, Willet WC, Mantzoros CS (2005). Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study. J Natl Cancer Inst, 97, 1688-94.
29. Yamauchi T, Kamon J, Ito Y, et al (2003). Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature, 423, 762-9.
30. Yamauchi T, Iwabu M, Okada-Iwabu M, Kadowaki T (2014). Adiponectin receptors: a review of their structure, function and how they work. Best Pract Res Clin Endocrinol Metab, 28, 15-23.
31. Yoneda K, Tomimoto A, Endo H, et al (2008). Expression of adiponectin receptors, AdipoR1 and AdipoR2, in normal colon epithelium and colon cancer tissue. Oncol Rep, 20, 479-83.
32. Zauber AG, Winawer SJ, O'Brien MJ, et al (2012). Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med, 366, 687-96.